Related Experiment Video
Updated: Mar 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D: A New Promising Therapy for Congenital Ichthyosis
Gomathy Sethuraman1, Raman K Marwaha2, Apoorva Challa3
1Departments of Dermatology kgsethu@yahoo.com aiimsgsr@gmail.com.
Insights
High-dose vitamin D supplementation significantly improved skin scaling and stiffness in children with congenital ichthyosis and vitamin D deficiency. This treatment offers a promising therapeutic approach for managing this condition.
Area of Science:
- Dermatology
- Endocrinology
- Pediatrics
Background:
- Congenital ichthyosis frequently co-occurs with severe vitamin D deficiency and rickets in children.
- Previous research has not described the effects of high-dose vitamin D supplementation on congenital ichthyosis symptoms.
Purpose of the Study:
- To investigate the clinical efficacy of short-term high-dose vitamin D supplementation in children with congenital ichthyosis and severe vitamin D deficiency.
- To evaluate the impact of this supplementation on skin scaling and stiffness.
Main Methods:
- Seven children with congenital ichthyosis and severe vitamin D deficiency received 60,000 IU of oral cholecalciferol daily for 10 days.
- Outcome measures included reduction in skin scaling and extremity stiffness.
- Patients were subsequently maintained on recommended daily allowances of vitamin D.
Main Results:
- Six out of seven patients showed significant improvement in skin scaling by day 5, with further improvement by day 10.
- Near-normal skin condition was observed in all autosomal recessive congenital ichthyosis cases after one month.
- All children experienced a remarkable reduction in skin stiffness.
Conclusions:
- Short-term high-dose vitamin D supplementation followed by maintenance therapy is an effective treatment for congenital ichthyosis associated with vitamin D deficiency.
- This approach offers a novel therapeutic strategy for improving skin manifestations in these patients.
Abstract:
Severe vitamin D deficiency and rickets are highly prevalent among children with congenital ichthyosis. We report an incidental observation of a dramatic and excellent clinical response with regard to skin scaling and stiffness in children with congenital ichthyosis after short-term high-dose vitamin D supplementation that has not been previously described. Seven children with congenital ichthyosis (5 with autosomal recessive congenital ichthyosis; 2 with epidermolytic ichthyosis) and severe vitamin D deficiency (and/or rickets) were given 60,000 IU of oral cholecalciferol daily for 10 days under supervision. All children were subsequently put on recommended daily allowance of 400 to 600 IU of cholecalciferol. The main outcome measures observed and studied were reduction in skin scaling and stiffness of the extremities. All cases had severe vitamin D deficiency (serum 25-hydroxyvitamin D < 4 ng/mL) and secondary hyperparathyroidism. Six patients had clinical and radiologic evidence of rickets. Significant improvement in scaling was noticeable by day 5, showing further improvement by day 10, in 6 of the 7 cases. At 1 month, the skin had become near normal in all the cases of autosomal recessive congenital ichthyosis. Remarkable reduction in stiffness was also observed in all children. Supplementation with high-dose vitamin D followed by recommended daily allowance appears to be an effective form of therapy in the management of congenital ichthyosis with vitamin D deficiency.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
iPS Cell Differentiation
Acne Infection
Chronic Kidney Disease III: Interprofessional Care
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

